A hepatitis B vaccine formulated with a novel adjuvant system

By Ambrosch F.   Wiedermann G.   Kundi M.   Leroux-Roels G.   Desombere I.   Garcon N.   Thiriart C.   Slaoui M.   Thoelen S.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2095-2101

Elsevier

Access to resources Recommend Favorite

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

By Heineman T.C.   Clements-Mann M.L.   Poland G.A.   Jacobson R.M.   Izu A.E.   Sakamoto D.   Eiden J.   Van Nest G.A.   Hsu H.H.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2769-2778

Elsevier

Access to resources Recommend Favorite

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

By Cryz S.J.   Poovorawan Y.   Theamboonlers A.   Chumdermpadetsuk S.   Gluck R.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 891-893

Elsevier

Access to resources Recommend Favorite

Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of India

By Lakshmi G.   Reddy R.P.S.   Kumar K.K.R.   Bhavani N.V.   Dayanand M.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2009-2014

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

By Raz R.   Dagan R.   Gallil A.   Brill G.   Kassis I.   Koren R.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 207-211

Elsevier

Access to resources Recommend Favorite